License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Available technologies
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
Cellular therapy for glaucoma
A cellular therapy to locally deliver nitric oxide (NO) to the conventional aqueous humour outflow pathway, thereby lowering eye pressure and preserving vision in glaucoma.
High-speed 3D Structured Illumination Microscopy (SIM)
A fast, achromatic, and light-efficient optical system that can record super-resolved Structured Illumination Microscopy (SIM) images at very high speeds, using only a single moving part.
An Inducible, multiplexed CRISPR system
A CRISPR-based platform for inducibly up- and down-regulating up to 24 genes in the yeast, Saccharomyces cerevisiae.
A real-time fluorescence probe for Heme Oxygenase activity
Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders.
System and method for real-time cochlear implant insertion control
A technique to minimize or eliminate damage created during the insertion of cochlear implants.
Highly Thermal Conductive Dielectric Polymers Films with Low Dielectric Loss and High Breakdown Strength for Energy Storage
Nanofiller/polymer composites films with enhanced thermal conductivity for use in thermal management, energy storage and electronic packaging
Functionalised biopolymer materials for extracellular vesicle isolation and engineering
Methods for use in extracellular vesicle (EV), including exosomes, isolation and engineering applications broadly encompassing EV manufacturing, therapeutic, medical and diagnostics uses.
Device for Injection of Biological Materials
An injector to reduce the damage to biological materials such as cells during an injection process and improve the survivability of the biological materials
Oligonucleotide Suppression Of Let-7 Binding By H19 To Reduce Sensitivity To Inflammation
novel oligonucleotides that bind to H19, displacing Let-7 miRNAs, leading to a reduction in inflammation in muscle tissues, and consequently a reduction in muscle wasting.
Media for the growth of Lactobacillus Iners
A novel growth medium for the culture of Lactobacillus iners to unprecedented high cell densities within 24 hours.
Licensing and IP performance 2019/20
Inventions disclosed
Imperial inventors submitted 250 invention disclosures to our IPC team during the year
Active licences
Imperial College London's licensing portfolio comprises 244 licences
Patents filed
Imperial filed 137 patents (including PCT applications) during the year
Patent portfolio
Imperial's patent portfolio reached 331 patents during the year
Featured inventor
Professor Naomi Chayen
Academic title - Prof Res Fellow - Professor of Biomedical Sciences
Faculty - Faculty of Medicine, Department of Metabolism, Digestion and Reproduction
Upcoming Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Latest News
Accelerated development of a potential treatment for cystic fibrosis
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Natural Killer – licensing a cell therapy
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial partner Apollo receives £100m to boost medical research at leading unis
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.